Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Coproporphyria × Sulindac × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Adenomatous Polyposis Coli 2 Pathologic Complete Response 1 Pancreatic Intraductal Neoplasms 1 Pain 1 Leukoplakia, Oral 1 Leukemia, Myeloid, Acute 1 Inflammation 1 Hypertension 1 Coproporphyria 1 Aberrant Crypt Foci 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00299195 2020-11-19

A Randomized Study of Sulindac in Oral Premalignant Lesions

Memorial Sloan Kettering Cancer Center

Phase NA Completed

63 enrolled 10 charts

Coproporphyria, Leukoplakia, Oral, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡